Evidence map›Paper›PMID 8816803›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1996

Interleukin 7 independent development of human B cells.

J A Prieyl, T W LeBien

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 142 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Regulation of Energy Metabolism during Early B Lymphocyte Development.International journal of molecular sciences · 2018
    Review
  8. Molecular Regulation of Differentiation in Early B-Lymphocyte Development.International journal of molecular sciences · 2018
    Review
  9. Article
  10. Review
  11. Article
  12. B cell biology: an overview.Current allergy and asthma reports · 2014
    Review
  13. Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.Cellular and molecular life sciences : CMLS · 2014
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

J A PrieylDepartment of Laboratory Medicine/Pathology, University of Minnesota Cancer Center, Minneapolis, USA.
T W LeBien
University of Minnesota · US

Funding

DIFFERENTIATIVE PROGRAMS OF LYMPHOID PROGENITOR CELLSR01CA031685 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LEBIEN, TUCKER W · 1985 to 2004
$1.7M
RETROVIRAL TRANSDUCTION OF LYMPHOCYTES FOR ANTI-LYMPHOMA THERAPYP01CA021737 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MILLER, WESLEY J · 1985 to 1997
–
NCI NIH HHS P01 CA-21737NCI NIH HHS R01 CA-31685
6 · The paper itself

Abstract

Mammalian hematopoietic stem cell (HSC) commitment and differentiation into lymphoid lineage cells proceed through a series of developmentally restricted progenitor compartments. A complete understanding of this process, and how it differs from HSC commitment and differentiation into cells of the myeloid/erythroid lineages, requires the development of model systems that support HSC commitment to the lymphoid lineages. We now describe a human bone marrow stromal cell culture that preferentially supports commitment and differentiation of human HSC to CD19+ B-lineage cells. Fluorescence activated cell sorterpurified CD34++/lineage-cells were isolated from fetal bone marrow and cultured on human fetal bone marrow stromal cells in serum-free conditions containing no exogenous cytokines. Over a period of 3 weeks, CD34++/lineage- cells underwent commitment, differentiation, and expansion into the B lineage. Progressive changes included: loss of CD34, acquisition of and graded increases in the level of cell surface CD19, and appearance of immature B cells expressing mu/kappa or mu/lambda cell surface Ig receptors. The tempo and phenotype of B-cell development was not influenced by the addition of IL-7 (10 ng/ml), or by the addition of goat anti-IL-7 neutralizing antibody. These results indicate a profound difference between mouse and human in the requirement for IL-7 in normal B-cell development, and provide an experimental system to identify and characterize human bone marrow stromal cell-derived molecules crucial for human B lymphopoiesis.

Indexed as

AnimalsAntibodies, MonoclonalAntigens, CDAntigens, CD19B-LymphocytesBone MarrowCell DifferentiationCells, CulturedCoculture TechniquesFetusFlow CytometryGoatsHematopoiesisHematopoietic Stem CellsHumansImmunoglobulin kappa-ChainsAntibodies, MonoclonalAntigens, CDAntigens, CD19Immunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsImmunoglobulin mu-ChainsInterleukin-7Receptors, Immunologic

Identifiers

PMID8816803
PMCPMC38387
OpenAlexW2163922871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.